FDA Approves New Over-the-Counter Pain Relief Pill Combining Acetaminophen and Naproxen Sodium
The FDA has approved an over-the-counter pill combining Tylenol (acetaminophen) and naproxen sodium (generic for Aleve) into a single tablet. This new medication is for adults and children aged 12 and older and will be available at major retailers for…
Pittsburgh, PA, July 28, 2026 —
The U.S. Food and Drug Administration (FDA) has granted approval for a new over-the-counter medication that combines two common pain relievers: acetaminophen (the active ingredient in Tylenol) and naproxen sodium (the active ingredient in Aleve). This marks the first time these two drugs will be available in a single pill without a prescription.
The newly approved medication is intended for adults and children aged 12 years and older. It is designed to provide temporary relief from a range of pain conditions, including headaches, back pain, muscle aches, toothaches, menstrual cramps, and minor arthritis pain. The combined formula is formulated to offer a duration of pain relief lasting up to 12 hours.
Availability of the new pill is expected at major retail locations. The FDA’s approval signifies that the drug has met the agency’s standards for safety and effectiveness when used as directed for the specified indications.
This development offers consumers a new option for managing common pain symptoms, potentially simplifying pain relief routines by consolidating two active ingredients into one dosage form. Further details regarding the specific brand name and launch date are anticipated as the product prepares for market release.
Story summarized from the original created by Bob D’Angelo, Cox Media Group National Content Desk on www.wpxi.com, see more information here.
Media gallery
